PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
Data generation and assessment | ARN | Regulatory risk management | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(1-methylethyl)-1,1'-biphenyl | 247-156-8 | 25640-78-2 | 1 | - | 2 | - | 1 | - | - | - | - | Details |
(-)-pin-2(10)-ene | 242-060-2 | 18172-67-3 | 1 | - | 1 | - | 1 | - | - | - | - | Details |
≥ 76.9% 3-[(1RS,3RS)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1RS,3SR)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin | - | - | - | - | - | - | - | 1 | - | - | - | Details |
λ²-iron(2+) lithium(1+) phosphate | 476-700-9 | 1199808-36-0 | - | - | 1 | - | - | - | - | - | - | Details |
ε-Caprolactone, oligomeric reaction products with propylidynetrimethanol | 500-099-5 | 37625-56-2 | - | - | 1 | - | - | - | - | - | - | Details |
ε-caprolactam | 203-313-2 | 105-60-2 | - | - | 1 | - | - | - | - | - | - | Details |
δ-valerolactone | 208-807-1 | 542-28-9 | - | - | 1 | - | - | - | - | - | - | Details |
γ-butyrolactone | 202-509-5 | 96-48-0 | - | - | 1 | - | - | 1 | - | - | - | Details |
β-methyl-3-(1-methylethyl)benzenepropanal
FLORHYDRAL
|
412-050-4 | 125109-85-5 | - | - | 2 | - | 1 | - | - | - | - | Details |
β-Alanine, N-coco alkyl derivs., sodium salts | 271-795-1 | 68608-68-4 | - | - | - | - | 1 | - | - | - | - | Details |